Dowling & Yahnke’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $9.11M | Buy |
105,758
+100
| +0.1% | +$8.93K | 0.42% | 52 |
|
|
2022
Q2 | $9.63M | Buy |
105,658
+581
| +0.6% | +$51.5K | 0.45% | 49 |
|
|
2022
Q1 | $8.62M | Buy |
105,077
+715
| +0.7% | +$56.4K | 0.37% | 73 |
|
|
2021
Q4 | $8M | Sell |
104,362
-1,778
| -2% | -$142K | 0.38% | 82 |
|
|
2021
Q3 | $7.97M | Sell |
106,140
-951
| -0.9% | -$72.3K | 0.44% | 71 |
|
|
2021
Q2 | $8.33M | Sell |
107,091
-3,076
| -3% | -$229K | 0.48% | 70 |
|
|
2021
Q1 | $8.1M | Sell |
110,167
-1,357
| -1% | -$100K | 0.55% | 55 |
|
|
2020
Q4 | $8.71M | Buy |
111,524
+6,066
| +6% | +$464K | 0.62% | 45 |
|
|
2020
Q3 | $8.35M | Buy |
105,458
+269
| +0.3% | +$21.1K | 0.67% | 41 |
|
|
2020
Q2 | $7.76M | Buy |
105,189
+643
| +0.6% | +$48.4K | 0.65% | 41 |
|
|
2020
Q1 | $7.67M | Sell |
104,546
-2,981
| -3% | -$234K | 0.74% | 36 |
|
|
2019
Q4 | $9.33M | Sell |
107,527
-2,713
| -2% | -$223K | 0.72% | 35 |
|
|
2019
Q3 | $8.86M | Buy |
110,240
+3,603
| +3% | +$289K | 0.73% | 33 |
|
|
2019
Q2 | $8.53M | Sell |
106,637
-1,636
| -2% | -$125K | 0.71% | 40 |
|
|
2019
Q1 | $8.59M | Buy |
108,273
+3,447
| +3% | +$258K | 0.83% | 32 |
|
|
2018
Q4 | $7.94M | Buy |
104,826
+2,101
| +2% | +$148K | 0.82% | 34 |
|
|
2018
Q3 | $6.95M | Sell |
102,725
-1,571
| -2% | -$100K | 0.61% | 51 |
|
|
2018
Q2 | $6.04M | Sell |
104,296
-1,367
| -1% | -$77.1K | 0.56% | 59 |
|
|
2018
Q1 | $5.49M | Sell |
105,663
-1,290
| -1% | -$69.7K | 0.51% | 66 |
|
|
2017
Q4 | $5.74M | Sell |
106,953
-4,472
| -4% | -$248K | 0.52% | 65 |
|
|
2017
Q3 | $6.81M | Sell |
111,425
-934
| -0.8% | -$56.6K | 0.69% | 45 |
|
|
2017
Q2 | $6.87M | Sell |
112,359
-588
| -0.5% | -$35.8K | 0.72% | 38 |
|
|
2017
Q1 | $6.85M | Sell |
112,947
-583
| -0.5% | -$35.4K | 0.73% | 41 |
|
|
2016
Q4 | $6.38M | Sell |
113,530
-591
| -0.5% | -$34.6K | 0.71% | 40 |
|
|
2016
Q3 | $6.8M | Sell |
114,121
-349
| -0.3% | -$20.4K | 0.79% | 32 |
|
|
2016
Q2 | $6.29M | Buy |
114,470
+1,729
| +2% | +$92K | 0.76% | 41 |
|
|
2016
Q1 | $5.69M | Buy |
112,741
+2,010
| +2% | +$98.4K | 0.7% | 44 |
|
|
2015
Q4 | $5.58M | Buy |
110,731
+1,437
| +1% | +$72.5K | 0.7% | 40 |
|
|
2015
Q3 | $5.15M | Buy |
109,294
+1,293
| +1% | +$68.7K | 0.7% | 42 |
|
|
2015
Q2 | $5.87M | Sell |
108,001
-420
| -0.4% | -$23.6K | 0.74% | 36 |
|
|
2015
Q1 | $5.95M | Sell |
108,421
-7,633
| -7% | -$432K | 0.74% | 35 |
|
|
2014
Q4 | $6.29M | Buy |
116,054
+1,743
| +2% | +$97.1K | 0.78% | 30 |
|
|
2014
Q3 | $6.47M | Sell |
114,311
-366
| -0.3% | -$20.6K | 0.85% | 23 |
|
|
2014
Q2 | $6.33M | Sell |
114,677
-3,938
| -3% | -$215K | 0.82% | 27 |
|
|
2014
Q1 | $6.42M | Buy |
118,615
+8,061
| +7% | +$417K | 0.85% | 26 |
|
|
2013
Q4 | $5.28M | Buy |
110,554
+5,641
| +5% | +$258K | 0.74% | 37 |
|
|
2013
Q3 | $4.77M | Buy |
104,913
+72
| +0.1% | +$3.29K | 0.75% | 36 |
|
|
2013
Q2 | $4.65M | Buy |
+104,841
| New | +$4.68M | 0.77% | 35 |
|
Other funds holding MRK
Dowling & Yahnke's MRK Position: Q3 2022 in Review
Dowling & Yahnke increased its Merck (MRK) stake by 0.09% in Q3 2022, buying an estimated $8.93K and bringing the position to 105,758 shares worth $9.11M. The position accounts for 0.42% of the portfolio, ranked #52.
Dowling & Yahnke first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.63M in Q2 2022. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- Dowling & Yahnke held 105,758 shares of Merck worth $9.11M as of Q3 2022.
- Dowling & Yahnke bought 100 Merck shares in Q3 2022, an estimated $8.93K.
- Merck made up 0.42% of Dowling & Yahnke's portfolio in Q3 2022, its #52 holding.
- Dowling & Yahnke first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- Dowling & Yahnke's Merck position peaked at $9.63M in Q2 2022.
- 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.